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ABSTRACT 18 
Epidermal homeostasis depends on a balance between self-renewal of stem cells and terminal 19 
differentiation of their progeny. Notch signalling is known to play a role in stem cell 20 
patterning and differentiation. However, the molecular mechanisms are incompletely 21 
understood. Here we demonstrate dynamic patterns of Notch ligand and receptor expression 22 
in cultured human epidermis. Notch2 and 3 act together to promote differentiation, while 23 
Notch1 decreases stem cell proliferation. The Notch ligand Jagged1 triggers differentiation 24 
when presented on an adhesive substrate or on polystyrene beads and over-rides the 25 
differentiation inhibitory effect of cell spreading. In contrast, Delta-like 1 (Dll1) 26 
overexpression abrogates the pro-differentiation effect of Jagged1 in a cell autonomous 27 
fashion. We conclude that Dll1 expression by stem cells not only stimulates differentiation of 28 
neighbouring cells in trans, but also inhibits differentiation cell autonomously. These results 29 
highlight the distinct roles of different Notch receptors and ligands in controlling epidermal 30 
homeostasis. 31 
 32 
Introduction 33 
Mammalian epidermis comprises a multi-layered epithelium, termed inter-follicular 34 
epidermis (IFE), with various associated appendages including hair follicles, sebaceous 35 
glands, and sweat glands1. Maintenance of the IFE and its appendages depends on several 36 
distinct stem cell (SC) populations1-4. IFE SCs reside in the basal cell layer of the epithelium 37 
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where they are anchored to an underlying basement membrane1. They divide to produce SCs 38 
that remain in the basal cell layer or cells that are destined to undergo terminal differentiation 39 
in the suprabasal cell layers1, 4, 5. Once terminal differentiation has been triggered, committed 40 
progenitors (CPs) detach from the basement membrane and become sorted into the suprabasal 41 
layers. There, they undergo a programmed series of morphological and biochemical changes 42 
that include the synthesis of the differentiation-specific keratins K1 and K10, as well as 43 
involucrin (IVL), transglutaminase (TGM) 1, periplakin (PPL), and loricrin6.  44 
The Notch signalling pathway plays an important role in regulating epidermal 45 
homeostasis7, 8. Notch receptors are initially synthesized as single precursor proteins, which 46 
are subsequently cleaved during transport to the cell membrane by a Furin-like convertase at 47 
site S18. S1 cleavage generates two subunits (extracellular domain (ECD) and transmembrane 48 
and intracellular domain (TMICD)) which are held together noncovalently at the cell 49 
surface8. Notch signalling is activated via interaction with ligands (such as Jagged1, Jagged2 50 
and Dll1) that are themselves transmembrane proteins and results in two successive 51 
proteolytic cleavages of the Notch receptor7, 8. The first cleavage is mediated by an ADAM 52 
family metalloprotease (tumor necrosis factor-α-converting enzyme, TACE), which cleaves 53 
the receptor at site S2, close to the transmembrane domain of the TMICD, to generate the 54 
Notch extracellular truncation (NEXT) fragment7, 8. The second cleavage is mediated by γ-55 
secretase and occurs intracellularly within the transmembrane domain of the NEXT fragment 56 
at site S3, resulting in the release of the Notch intracellular domain (NICD) into the 57 
cytoplasm7, 8. The NICD translocates into the nucleus and forms a complex with a 58 
transcriptional coactivator, leading to the activation of Notch target gene transcription7, 8.  59 
Genetic ablation or activation of the Notch pathway has revealed that a key function 60 
of epidermal Notch signalling is promotion and maintenance of the differentiated cell state7, 8. 61 
However, there is ambiguity about the precise roles of the different Notch receptors, as both 62 
specific and redundant signalling functions have been reported9-12. Likewise, it is unknown 63 
whether, as in other tissues, different Notch ligands transduce distinct signals by 64 
preferentially engaging with specific receptors13-15. All Notch ligands likely have dual 65 
functions, as exemplified by Dll1: it initiates Notch signalling in a neighbouring cell in-trans 66 
and initiates a PDZ-dependent signalling mechanism in-cis16. The complexity of Notch 67 
signalling is further increased by the phenomenon of cis-inhibition, a mechanism whereby 68 
Notch ligands engage with receptors in the same cell to inhibit or dampen Notch signals 69 
transduced in-trans via Notch ligands on the surface of neighbouring cells17, 18. A higher 70 
3 
 
tendency of Dll1 null keratinocytes to initiate terminal differentiation19 could indicate that 71 
such a mechanism is operating in the IFE SC compartment. 72 
In this study, we demonstrate that different Notch receptors and ligands play 73 
overlapping but distinct roles in controlling terminal differentiation in the human IFE and 74 
provide new mechanistic insights into how Notch signalling is regulated to maintain a 75 
balance between SC renewal and differentiation.  76 
 77 
Results 78 
Dynamic expression of Notch signaling components in cultured human epidermis 79 
When human epidermal SCs are deprived of extracellular matrix (ECM) adhesion by 80 
culturing them in suspension (0h), they rapidly transit through a commitment stage (4h) to 81 
undergo terminal differentiation by 12 h in suspension20. By examining a previously 82 
published microarray dataset20, we found that Notch1 levels declined in suspension, while 83 
there was a moderate upregulation of Notch2 from 8h to 12 h and strong induction of Notch3 84 
from 4 to 12h. (Fig. 1a). Expression of the terminal differentiation markers IVL and TGM1 85 
increased from 8h, whereas SC markers (ITGB1, TP63)5, 20 were downregulated (Fig. 1c). 86 
Expression of the Notch ligands Dll1 and Jagged2 decreased in suspension, whereas Jagged1 87 
remained relatively constant during the first 8h of suspension-induced differentiation (Fig. 88 
1b). Similar changes in Notch1/2/3, Dll1 and Jagged1/2 expression are observed during 89 
terminal differentiation of developing mouse interfollicular epidermis21.  90 
To assess whether the observed changes in Notch receptor and ligand expression also 91 
occurred in adherent cultures, we disaggregated preconfluent stratified colonies of human 92 
keratinocytes and enriched for SC (rapidly adherent), CP (slowly adherent) or terminally 93 
differentiating (non-adherent) cells by differential adhesion to ECM22 (Fig. 1d). Q-RT PCR 94 
analysis of the Notch signalling target genes HES1, HEY1 and IRF623 showed that, relative 95 
to SC, expression was highest in the CP-enriched fraction (Fig. 1e). Notch1 was the 96 
predominant receptor expressed by epidermal SCs (Fig. 1f, h), while expression of Notch3 97 
was upregulated in terminally differentiated cells (Fig. 1f, h), consistent with the induction of 98 
expression in suspension (Fig. 1a). Jagged1 was the major Notch ligand expressed in all cell 99 
fractions, and Dll1 and Jagged2 levels declined during terminal differentiation (Fig. 1g, h). 100 
Notch4, Dll3 and Dll4 were not detected (Fig. 1f, g). 101 
We also examined the relative levels of total and activated Notch proteins in the 102 
different cell fractions by western blotting with antibodies to the TMICD or NICD (generated 103 
by S3 cleavage) of Notch1, the TMICD of Notch2, or the TMICD and NEXT fragment 104 
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(generated by S2 cleavage) of Notch324 (Fig. 1i) Antibody specificity was confirmed by 105 
probing lysates of cells expressing shRNAs for each receptor (Suppl. Fig. 1a, b). The level of 106 
activated Notch1 declined in CP and differentiated cells relative to SC, whereas the levels of 107 
Notch3 increased, consistent with the changes in mRNA levels. Notch2 levels were lower in 108 
CP than in the other populations, but this was not reflected in decreased mRNA levels (Fig. 109 
1f, h, i), potentially indicating strong receptor activation leading to a decrease in the levels of 110 
the TMICD24. Indeed, inhibition of S3 cleavage using the γ-secretase inhibitor DAPT led to 111 
accumulation of the Notch2 TMICD and NEXT fragment in cells grown in standard culture 112 
medium (FAD), but not in low calcium medium (KSFM), and also resulted in decreased IVL 113 
expression (Fig. 1j). The dynamics of Notch receptor and ligand expression are summarised 114 
schematically in Fig. 1k. 115 
 116 
Distinct and and overlapping effects of Notch receptors and ligands on differentiation 117 
To test the functions of different Notch receptors, we silenced their expression in human 118 
keratinocytes using two sets of different shRNAs (Fig. 2a–d; Suppl. Fig. 1a, b; Suppl. Table 119 
5), and allowed the cells to form stratified epidermal sheets25, 26. We found that knockdown of 120 
Notch2 or Notch3 inhibited terminal differentiation, as evidenced by reduced expression of 121 
IVL and increased expression of ITGB1 (Fig. 2a, Suppl. Fig. 1a). The effect on terminal 122 
differentiation was even more pronounced using a shRNA that reduced the expression of 123 
Notch2 and Notch3 (Fig. 2a).  124 
 125 
Knockdown of Notch1 led to only a small increase in ITGB1 expression and did not impair 126 
terminal differentiation (Fig. 2a, Suppl. Fig. 1a). However, keratinocytes expressing Notch1-127 
targeting shRNAs formed larger colonies than cells expressing a non-targeting shRNA (Fig. 128 
2b, c) and were more proliferative (Fig. 2d). There was also a reduction in abortive clones 129 
formed by shNotch1-expressing cells (Suppl. Table 1)11, 16. Together, our findings indicate 130 
increased SC proliferation on Notch1 knockdown27, 28. We conclude that Notch1 functions to 131 
reduce expansion of the epidermal SC compartment, as previously shown in the context of 132 
mouse epidermis11, 12, 29, while Notch2 and Notch3 cooperate to promote terminal 133 
differentiation. 134 
 135 
We next examined the response of keratinocytes to different Notch ligands. To this end we 136 
functionalized cell culture surfaces with mixtures of fibronectin (FN) and immobilized 137 
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recombinant Fc-tagged Notch ligands (Fig. 2e). This strategy allowed us to enrich for SC on 138 
the basis of rapid FN adhesion22, and measure differentiation and Notch target gene 139 
expression in the presence or absence of DAPT. Indirectly immobilized antibodies to the β2 140 
microglobulin (β2MG) subunit of the major histocompatibility complex acted as control 141 
substrates (Fig. 2e)30. 24 hours after seeding, a fraction of single keratinocytes exposed to 142 
Jagged1 and Jagged2 displayed enlarged and elongated shapes typical of terminally 143 
differentiating cells31, while exposure to Dll1 ligands or anti-β2MG antibodies had no such 144 
effect (Fig. 2f, g). Q-RT PCR analysis confirmed the induction of terminal differentiation 145 
marker (TGM1, IVL) expression by Jagged1 and Jagged2, correlating in each case with 146 
upregulation of the Notch signalling target genes HES1 and IRF6 (Fig. 2h). Since we did not 147 
test dose-responsiveness for the different Notch ligands, we cannot rule out the possibility 148 
that higher concentrations of recombinant Dll1 might also induce differentiation. 149 
 150 
To examine differential activation of specific Notch receptors we exploited the fact that 151 
prolonged exposure to Notch ligand leads to reduced TMICD levels due to persistent S2 and 152 
S3 cleavage24. Under such conditions, parallel treatment with DAPT to block S3 cleavage 153 
causes accumulation of the NEXT fragment, thereby confirming that the observed reduction 154 
of TMICD levels is specifically caused by receptor activation24. Western blotting with 155 
antibodies detecting the TMICD and the NEXT fragment produced by S2 cleavage revealed 156 
that all Notch receptors were most potently activated by Jagged1 (Fig. 2i). ITGB1 was 157 
downregulated in response to Jagged1 and 2 but not Dll1. These findings confirm that 158 
engagement of Jagged1 and 2 with Notch receptors promotes terminal differentiation.  159 
 160 
Notch signalling can over-ride cell spreading to induce terminal differentiation 161 
In vitro, terminal differentiation can be induced through distinct cellular signalling pathways, 162 
including—in addition to Notch signalling—serum stimulation, inhibition of EGFR 163 
signalling, stimulation with BMP2/7, and restricted cell spreading32-34. To examine the 164 
response of individual keratinocytes to the combined stimuli of cell spreading and Notch 165 
activation, we employed arrays of micropatterned 20 and 50 μm diameter circular adhesive 166 
islands to selectively capture single epidermal SCs35. Cells captured on the small adhesive 167 
islands do not spread and are stimulated to differentiate due to activation of serum response 168 
factor (SRF) and nuclear exclusion of YAP/TAZ downstream of actin polymerisation32, 34.  169 
 170 
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By functionalising the adhesive islands with mixtures of FN and indirectly immobilized 171 
Notch ligands we asked if exposure to a Notch signal could over-ride the anti-differentiation 172 
effect of cell spreading on large islands (Fig. 3a). Single cells undergoing terminal 173 
differentiation were identified using an automated high content imaging analysis pipeline 174 
(Suppl. Fig. 2a). While 48 hours of exposure to Jagged1 and Jagged2 ligands increased the 175 
frequency of single cells that differentiated on large islands, this was not the case for cells on 176 
small islands (Fig. 3b, Suppl. Fig. 2b, Suppl. Table 2). Consistent with previously published 177 
findings34, we observed a trend towards reduced numbers of differentiating cells on small 178 
islands upon DAPT treatment. However, overall, this trend was not statistically significant 179 
(Fig. 3b, Suppl. Fig. 2b, Suppl. Table 2).  180 
 181 
To test if a localized Notch signal could induce differentiation, we exposed cells captured on 182 
50 μm diameter adhesive islands to 10 μm diameter fluorescent microbeads functionalized 183 
with recombinant Jagged1 or anti-β2MG antibodies (Fig. 3c, d). To confirm that the two 184 
high-affinity protein interactions used to functionalise the beads (streptavidin–biotin and 185 
protein G–Fc-tag) resulted in presentation of the ligands in the appropriate conformation and 186 
density to induce the correct biological response at the cell surface, we performed pilot 187 
experiments using beads functionalized with recombinant E-cadherin36 (Suppl. Fig. 2c–e). 188 
We found that, as anticipated, such beads were captured by the cells in a calcium-dependent 189 
fashion (Suppl. Fig. 2d), and we observed clustering of endogenous α-catenin molecules at 190 
the bead-cell interface, indicating formation of adherens junctions36 (Suppl. Fig. 2e). To 191 
facilitate detection of single cells with a single attached bead, we also developed a semi-192 
automated high content imaging analysis pipeline (Suppl. Fig. 2f). We found that, in 193 
comparison to beads functionalised with anti-β2MG antibodies, attachment of single 194 
Jagged1-functionalised beads led to a substantial increase in the numbers of cells that 195 
differentitated within 24 hours as assessed by TGM1 staining (Fig. 3e, f). These findings 196 
support a mechanism whereby a localised Notch signal is able to induce the terminal 197 
differentiation programme in single human epidermal SCs. 198 
 199 
Cis inhibition mediated by Dll1 inhibits Jagged-induced differentiation 200 
Our studies point to a different role for Dll1 compared to Jagged1 and Jagged2 in regulating 201 
exit from the SC compartment, consistent with earlier studies demonstrating that 202 
keratinocytes expressing high Dll1 levels induce differentiation in neighbouring cells with 203 
lower Dll1 levels24, 25. To re-assess the function(s) of Dll1 in human keratinocytes, we 204 
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knocked down endogenous expression by RNA interference. Although it is more difficult to 205 
silence the expression of weakly than highly expressed genes37, we were able to identify one 206 
siRNA that reduced the levels of Dll1 mRNA by over 50% without considerably affecting 207 
Jagged1 and 2 levels (Fig. 4a). Dll1 knock down led to a significant increase in expression of 208 
the Notch target gene IRF6 (Fig. 4b) and the differentiation markers IVL and TGM1 (Fig. 209 
4c), as well as reduced colony formation (Fig. 4d). These results suggest that Dll1 has a cis-210 
inhibitory function that renders Notch receptors on the surface of SCs non-responsive to 211 
ligand stimulation by neighbouring cells17, 38. 212 
 213 
To test whether such a mechanism was indeed operating in the human epidermal SC 214 
compartment, we overexpressed zebrafish Dll1(zDll1)16 in two different strains of human 215 
keratinocytes (Suppl. Fig. 3) and seeded cells at low cell density onto substrates 216 
functionalized with Jagged1 and Jagged2 (Fig. 4e). In this experimental setup, zDll1-217 
mediated cis-inhibition of endogenous Notch receptors should block the response to Jagged1 218 
and Jagged2. Consistent with this hypothesis, the Jagged1- and Jagged2-induced increase in 219 
IVL and PPL expression was prevented in cells overexpressing zDll1 (Fig. 4g, f). Thus, we 220 
conclude that a major function of Dll1 in the human IFE stem cell compartment is to cis-221 
inhibit Notch signals from neighbouring cells. 222 
 223 
Discussion 224 
It is well known that the Notch signalling pathway plays a central role in epidermal 225 
homeostasis and that Notch inactivation has a pro-tumorigenic effect in multilayered 226 
epithelia. However, the ways in which Notch executes these functions are highly complex 227 
and include cell autonomous and non-cell autonomous signalling within the epidermis, 228 
synergistic and antagonistic relationships with other signalling pathways, notably Wnt, Notch 229 
and YAP, and communication between the epidermis and cells of the immune system and 230 
stroma8, 39-41. We have now used cultured human keratinocytes to map the changes in 231 
expression of Notch receptors and ligands associated with exit from the SC compartment and 232 
to perform functional assays of the effects of gene knockdown. 233 
 234 
Our findings indicate that inactivation of Notch2 and Notch3 inhibit terminal differentiation, 235 
while Notch1 knockdown has a more pronounced effect on proliferation than terminal 236 
differentiation. Jagged1 and Jagged2 act as terminal differentiation stimuli, while Dll1 has the 237 
opposite effect. The ability of Jagged1 and Jagged2 to promote differentiation of spread 238 
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keratinocytes on micropatterned islands leads us to speculate that Notch signalling may 239 
activate the SRF pathway and inactivate YAP/TAZ, providing an interesting counter-point to 240 
the observation that Notch and Hes1 are repressed in SRF knockout mouse epidermis42 and 241 
that knockdown of YAP/TAZ in human keratinocytes activates Notch signalling34. The 242 
concept of an interplay between Notch, SRF and YAP/TAZ signalling is supported by our 243 
finding that DAPT partially inhibits differentiation of rounded cells on micropatterned 244 
substrates.  245 
 246 
The function of the Notch ligand Dll1 is particularly intriguing. Dll1 expression is patterned 247 
within the basal layer of fetal human and mouse epidermis16, 43, and in human epidermis the 248 
distribution of Dll1+ basal layer clusters matches the distribution of stem cells43. In addition 249 
Dll1 is transcriptionally controlled in a mechano-sensitive manner by YAP and TAZ34. Single 250 
cell gene expression profiling indicates that in culture there are two SC subpopulations that 251 
differ in Dll1 expression, but not in expression of Notch pathway genes44. The Dll1 252 
cytoplasmic domain binds syntenin and this association mediates stem cell clustering in 253 
vitro16, 45. Knockdown of syntenin increases Dll1-dependent Notch activation16. Our studies 254 
provide experimental evidence for a recently proposed new function for Dll1 within stem cell 255 
clusters, namely preventing Notch signalling-mediated differentiation by cis-inhibiting Notch 256 
receptors from receiving signals in-trans34. It will now be of interest to examine how Dll1 257 
expression affects the integration of signals involving Notch and additional pathways. 258 
 259 
Materials and Methods 260 
 261 
Human tissues No human tissue was collected as part of this study. The human cells that we 262 
cultured for this study were isolated prior to 2004 and cryopreserved. Therefore, the tissue 263 
from which they were isolated is not covered by the UK Human Tissue Act (2004). 264 
  265 
Cell culture Stock cultures of human keratinocytes (strains kn and km) from neonatal 266 
foreskin epidermis were used at passages 3–6. Each strain name refers to an individual 267 
foreskin. Primary cell cultures were established from surgically discarded neonatal foreskins 268 
as described8-10, expanded at passage 1 and then frozen down to prepare stock cultures. 3T3-269 
J2 fibroblasts were originally obtained from Dr. James Rheinwald (Department of 270 
Dermatology, Harvard Skin Research Centre, USA) and were not authenticated. All cell 271 
stocks were routinely tested for mycoplasma contamination and were negative.  272 
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 273 
Human keratinocytes were cultured in complete FAD medium, containing 1 part Ham's F12, 274 
3 parts Dulbecco's modified Eagle’s medium (DMEM), 10−4 M adenine, 10% (v/v) FBS, 275 
0.5 μg ml−1 hydrocortisone, 5 μg ml−1 insulin, 10−10 M cholera toxin and 10 ng ml−1 EGF, on 276 
mitotically inactivated 3T3-J2 cells as described previously22, 25, 35. 3T3-J2 cells were cultured 277 
in high-glucose DMEM (Sigma-Aldrich) supplemented with 100 IU ml−1 penicillin, 100 μg 278 
ml−1 streptomycin, 10% (v/v) adult BS (Life Technologies)35. 3T3-J2 cells were inactivated 279 
by mitomycin C-treatment (3 h, 4 μg ml−1 final concentration, Sigma-Aldrich)35.  280 
 281 
In some experiments human keratinocytes were seeded at a density of 3.5 x 104 cells cm−2 282 
into cell culture dishes (Falcon) coated with rat-tail collagen type I (20 µg ml−1 in PBS, BD 283 
Biosciences), grown to confluence in keratinocyte serum-free medium (KSFM) containing 30 284 
µg ml−1 bovine pituitary extract and 0.2 ng ml−1 EGF (Thermo Fisher Scientific) and then 285 
switched to complete FAD medium to induce terminal differentiation and stratification35. For 286 
experiments using glass micro-chips containing micro-patterned arrays of circular islands, 287 
pre-confluent human keratinocytes were gently disaggregated in trypsin/EDTA following 288 
removal of the feeder layer, filtered twice through a 40 µm cell strainer (Falcon) and re-289 
seeded onto the substrates at a density of 1 x 104 cells cm−2 in KSFM supplemented with 10 290 
µM of the γ-secretase inhibitor DAPT. DAPT was obtained from Sigma-Aldrich (D5942) and 291 
dissolved in sterile DMSO to obtain a 20 mM stock solution. To prevent auto-activation of 292 
Notch receptors due to chelation of Ca++ ions46, DAPT (10 µM) was also present during 293 
feeder layer removal and trypsinisation. Cells were allowed to adhere for 2 h and the 294 
substrates were then rinsed five times with fresh medium to remove non-attached cells35. 295 
Cells were subsequently cultured in complete FAD medium without DAPT for up to 48 296 
hours. 297 
 298 
Cell fractions enriched for human epidermal stem cells, committed progenitors and terminally 299 
differentiated cells were prepared as described22, 35 by adhesion to human placenta collagen 300 
type IV (Sigma-Aldrich). In some experiments cells were transduced with an empty vector 301 
(EV) or a zDll1 retroviral vector, as described previously16. Expression of the zDll1 transgene 302 
was validated by immunofluorescence microscopy using zDll1-specific antibodies16. 303 
 304 
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Clonal growth assays 100 live (Trypan Blue-negative) human keratinocytes were seeded per 305 
condition into triplicate wells (containing a 3T3-J2 feeder layer) of a 6-well dish (Falcon). 306 
After 12 days, feeder cells were removed by rinsing with EDTA and colonies were either 307 
fixed in 4% (w/v) paraformaldehyde for 10 min and stained with 1% Rhodanile Blue (1:1 308 
mixture of Rhodamine B and Nile Blue A (Acros Organics))22, or simultaneously fixed and 309 
stained with Crystal Violet solution (0.4% (w/v) crystal violet, 20% (v/v) methanol)35. 310 
Colonies were imaged and counted using an automated cell colony counter (Gelcount™, 311 
Oxford Optronix, UK), and colony forming efficiency (CFE) was calculated as the average 312 
percentage of seeded cells that formed colonies35. Colony area was measured using the Fiji 313 
image processing software package and the “Analyze Particles” tools, with a minimum 314 
particle size of 0.01 mm2 35. Colonies were scored as abortive if they contained fewer than 40 315 
cells, the majority of the cells being large and terminally differentiated43. 316 
 317 
Microfabrication CYTOOchips™ custom-manufactured composite micropatterned glass 318 
slides containing arrays of 20 and 50 µm diameter circular islands were purchased from 319 
CYTOO (Grenoble, France)35. The custom-designed template masks to print new slides are 320 
available upon request (Custom_CC20_Q13-24-38).  321 
 322 
Preparation of functionalised substrates 6-well plates (Falcon) were first coated with a 323 
mixture of recombinant protein G (4 µg/cm2) (Invitrogen) and human fibronectin (4 µg/cm2) 324 
(Corning) diluted in PBS over night (o/n) at room temperature (RT). Unbound proteins were 325 
removed by washing the plates three times with PBS, followed by blocking with 1% (w/v) 326 
BSA in PBS at RT for 1 hour. Wells were incubated for 4 h at RT with recombinant Fc-327 
tagged Notch ligand proteins Dll1 (Adipogen Life Science), Jagged1 and Jagged2 (R&D) or 328 
antibodies against the β2 microglobulin (β2MG) subunit of the human major 329 
histocompatibility complex (Abcam) (2.5 µg/cm2), diluted in 0.1% (w/v) BSA in Hanks 330 
Buffered Salt Solution (HBSS). Any protein not bound to protein G was removed by washing 331 
the substrates three times with HBSS. Glass microchips containing micropatterned arrays of 332 
20 μm and 50 μm circular islands were placed into 6-well plates (Falcon) and functionalised 333 
as described above. Functionalised substrates were prepared fresh for each experiment and 334 
kept in HBSS until use.  335 
   336 
Preparation of functionalised microbeads 200 µl (~3.4 x 106 beads) ProActive FlashRed-337 
fluorescent (excitation wavelength 660 nm, emission wavelength 690 nm) streptavidin-coated 338 
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polystyrene microbeads (SuperAvidin™ Microspheres, Bangs Laboratories, mean diameter 339 
10.14 µm) were resuspended by vortexing (30 sec), followed by sonication in a waterbath 340 
(Camsonix C-Series Heated Ultrasonic Cleaning Baths, Camlabs) for 30 sec at RT. Beads 341 
were then pelleted by centrifugation (1,200xg for 15 min at RT) and washed twice with 1 ml 342 
PBS. Beads were resuspended in 500 µl PBS containing 100 µg ml-1 biotinylated protein G 343 
(Sigma), and incubated overnight with constant rotation at 4°C. After two cycles of 344 
centrifugation and resuspension in PBS, beads were resuspended in 200 µl HBSS and added 345 
to 200 µl HBSS containing either 20 µg recombinant Fc-tagged Jagged1 (R&D) or 20 µg of 346 
antibodies against the β2 microglobulin (β2MG) (Abcam), and incubated overnight with 347 
constant rotation at 4°C. Beads were then washed twice in HBSS and blocked by subsequent 348 
incubations with 15 mM biotin (Sigma) and 1% (w/v) BSA in HBSS (1 h each) with constant 349 
rotation at RT. After two washing cycles in HBSS, beads were added to cells captured on 350 
glass micro-chips containing micro-patterned arrays of 20 and/or 50 µm diameter circular 351 
islands. After a 3 h incubation period, non-cell-attached beads were washed away, and cells 352 
were cultured for further 24 h.  353 
 354 
RNA extraction and quantitative real time PCR Total RNA was isolated from cultured 355 
cells using the RNeasy kit (Qiagen)35. Complementary DNA was generated using the 356 
QuantiTect Reverse Transcription kit (Qiagen). Q-RT PCR analysis of cDNA was performed 357 
using either qPCR primers (published or designed with Primer3) and Fast SYBR green 358 
Master Mix (Life Technologies), or Taqman probes and TaqMan Fast Universal PCR Master 359 
Mix (Thermo Fisher Scientific)35. RT-qPCR reactions were run on CFX384 Real-Time 360 
System (Bio-Rad)35. 18S rRNA, GAPDH and TBP were used as housekeeping genes for 361 
normalization35. Please refer to Supplementary Table 3 for qPCR oligos sequences and 362 
Taqman probes.  363 
 364 
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siRNA transfection siRNA nucleofection was performed with the Amaxa 96-well shuttle 365 
system (Lonza)35. Pre-confluent human keratinocyte cultures were disaggregated and re-366 
suspended in cell line buffer SF (Lonza). For each 20 μl transfection (program FF-113) 367 
reaction, 2 × 105 cells were mixed with 1 μM siRNA duplexes as described previously33, 35. 368 
Transfected cells were allowed to recover at ambient temperature for 10 min and were 369 
subsequently re-plated into rat-tail type I collagen (20 µg ml−1 in PBS, BD Biosciences)-370 
coated cell culture well plates (Falcon) and grown in KSFM for 24 h before being used for 371 
downstream assays35. 27mer siRNA oligo duplexes (SR509346, Origene) were used for gene 372 
knockdown of human DLL1 (the sequences of siRNA oligos can be found in Supplementary 373 
Table 4). Non-targeting control siRNAs were from Ambion (AM4611 and AM4637).  374 
 375 
shRNA-mediated gene silencing Human keratinocytes, cultured on feeder cells to ~70% 376 
confluence, were disaggregated in trypsin/EDTA and cells (5 x 105) were seeded into 6-well 377 
cell culture plates (Falcon) coated with rat-tail collagen type I (20 µg ml−1 in PBS, BD 378 
Biosciences), and cultured for 24 h in KSFM medium35. Cells were then infected with 379 
MISSION® lentiviral particles (Sigma-Aldrich, the sequences of the shRNAs can be found in 380 
Supplementary Table 5) at a MOI of 3 in the presence of 5 µg ml−1 polybrene (Sigma-381 
Aldrich)35. Medium was replaced after 24 h and shRNA-expressing cells were selected for 72 382 
h using puromycin (2 µg ml−1, Sigma-Aldrich)35.  383 
 384 
Immunofluorescence microscopy of cultured cells Cultured cells grown on CYTOO 385 
microchips or on glass coverslips (coated with rat-tail type I collagen (20 µg ml−1 in PBS, BD 386 
Biosciences) were fixed in 4% (w/v) paraformaldehyde (Sigma) for 10 min and 387 
permeabilized with 0.2% (v/v) Triton X-100 for 5 min at ambient temperature35. Human 388 
keratinocyte colonies grown in the presence of a 3T3-J2 feeder layer were fixed in 4% (w/v) 389 
paraformaldehyde (Sigma) for 45 min and permeabilized with 0.5% (v/v) Triton X-100 for 390 
45 min at ambient temperature35. Samples were blocked for 1h in 10% (v/v) FBS plus 0.25% 391 
(v/v) fish skin gelatin (Sigma-Aldrich) in 1x PBS (blocking buffer), and incubated with 392 
primary antibodies (diluted in blocking buffer) in a humid chamber overnight at 4°C35. After 393 
washing with PBS, samples were incubated with Alexa Fluor®-conjugated secondary 394 
antibodies for 2 h at room temperature35. Primary antibodies are listed in Supplementary 395 
Table 6. Rhodamine–phalloidin (Thermo Fisher Scientific) was included in the secondary 396 
antibody solution where indicated to stain filamentous actin. Fixed and stained coverslips 397 
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were mounted on glass slides with ProLong® Gold anti-fade reagent containing DAPI 398 
(Thermo Fisher Scientific)35. Confocal images were acquired with a Nikon A1r point 399 
scanning confocal fluorescence microscope equipped with a Plan Apo VC 20x DIC N2 400 
objective (Nikon) and controlled by NIS elements C software. Digital images were processed 401 
using NIS elements Advanced Research and Adobe software packages. 402 
 403 
High content imaging analysis Cells were processed for immunofluorescence microscopy as 404 
described above. Automated image acquisition was performed on an Operetta® high content 405 
imaging system (Perkin Elmer)35. For imaging, the entire CYTOO chip area was scanned; 406 
fields without fluorescence artefacts were selected, and z-stack images (z dimension 1 µm) 407 
were acquired using 10x long WD objectives via DAPI (50ms exposure), Alexa-488 (200ms 408 
exposure) and Alexa-594 (200ms exposure) channels35. Images were analysed using custom 409 
algorithms in the Harmony® high-content analysis software package (Perkin-410 
Elmer)35(Supplementary Fig. 2a, f). For all image analyses, cells were initially defined using 411 
the DAPI channel, then the cytoplasm was segmented using one of the Alexa channels. 412 
Single cells and cell clusters were identified and separated using linear classifiers defined 413 
through PhenoLOGIC machine learning within Harmony® software. Terminally 414 
differentiating cells were identified based on the presence of TGM1 fluoresence signals after 415 
background correction. The complete Harmony® image analysis sequences is available on 416 
request. 417 
 418 
Western blotting Cells were lysed on ice for 30min in 1x RIPA buffer (Cell Signalling 419 
Technology) supplemented with PhosSTOP® Phosphatase Inhibitor and cOmplete® EDTA-420 
free Protease Inhibitor Cocktails (Roche), and RIPA-soluble and -insoluble proteins were 421 
separated via centrifugation (16,000xg for 20min at 4°C)35. The amount of total protein was 422 
quantified in RIPA extracts using the BCA kit (Pierce). Equivalent quantities of RIPA-423 
solubilized proteins were resolved by SDS-PAGE in 4–20% Criterion TGX Stain-Free 424 
Precast Gels and transferred to Immun-Blot® Low Fluorescence PVDF membranes (Bio-Rad 425 
Laboratories) using the Trans-Blot® Turbo transfer system (Bio-Rad Laboratories)35. Protein 426 
transfer and equal protein loading were confirmed by enhanced tryptophan fluorescence 427 
imaging of PVDF membranes (Bio-Rad Laboratories)35. Membranes were blocked with 428 
either 5% (w/v) non-fat milk supplemented with 0.05% (v/v) Tween-20 (PBS-T) and then 429 
probed with the indicated antibodies diluted in blocking buffer. Primary antibodies are listed 430 
in Supplementary Table 6. Primary antibody-probed blots were visualized with appropriate 431 
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horseradish peroxidase-coupled secondary antibodies (Jackson ImmmunoResearch) using 432 
enhanced chemiluminescence (Clarity™ Western ECL, Bio-Rad Laboratories) according to 433 
the manufacturer's instructions35. Protein bands were detected using a ChemiDoc Touch 434 
Imaging System (Bio-Rad Laboratories)35. Processing of western blot images was done by 435 
Image Lab software (Bio-Rad Laboratories)35. For quantification of band intensities, 436 
exposures within the dynamic range were chosen35. Images of uncropped blots are shown in 437 
Supplementary Fig. 4. 438 
 439 
Computational analysis of gene expression datasets This was performed as described 440 
using microarray datasets obtained from human keratinocytes undergoing suspension-induced 441 
terminal differentiation20 (GEO databank GSE73147).  We performed pairwise comparison 442 
between 0 h and 4, 8 and 12 h, and between 0 h and 4 h, 4 h and 8 h, and 8 h and 12 h. 443 
Heatmaps were generated using opensource Multiple Experiment Viewer (MeV_4_8) 444 
software. 445 
 446 
Reproducibility of experiments For fractionation of human keratinocyte cultures, 5 447 
independent experiments were performed using independent cell stocks. Experiments 448 
involving micropatterned substrates were performed independently three times (using 449 
independent cell stocks and freshly functionalised substrates). Experiments involving shRNA 450 
treatments were performed with two different sets of shRNAs in two different strains of 451 
human keratinocytes, with comparable results. For clonal growth assays 2–3 independent 452 
experiments were performed with 2–3 technical replicates per condition. For western blotting 453 
experiments, representative blots from one of two experiments are shown. For 454 
immunostaining, representative images from one out of two experiments are shown. Q-RT 455 
PCR analysis was performed on four technical replicates. For cis-inhibtion of Notch 456 
signalling, we perfomed two independent experiments using two different strains of human 457 
keratinocytes, independently infected with zDll1-expressing retrovirus, with two technical 458 
replicates per experiment. 459 
 460 
Statistics and graph generation No statistical method was used to predetermine sample 461 
size. Statistical tests used to determine p values are specified in Figure Legends. All graphs 462 
were generated using GraphPad Prism 7.  463 
 464 
Antibodies Primary antibodies are listed in Supplementary Table 6.  465 
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Figure legends 496 
Figure 1 Dynamic expression pattern of Notch signalling components in human keratinocyte 497 
cultures. (a–c) Heatmaps showing Log2 fold change of normalised gene expression for 498 
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pairwaise comparisons of mRNA levels of Notch receptors (Notch1(N1), Notch2(N2), 499 
Notch3(N3)) (a), Notch ligands (Delta-like1(Dll1), Jagged1(JAG1), Jagged2(JAG2) (b) and 500 
stem cell (SC)/terminal differentiation markers (c) during suspension culture. For each 501 
condition the mean of n = 3 independent replicates in the microarray dataset was used and the 502 
pairwise fold change comparison was between the means of both samples. (d–h) Q-RT PCR 503 
analysis of mRNA levels of terminal differentiation marker (d), Notch signalling target genes 504 
(e), and Notch receptors and ligands (f–h) in enriched populations of stem- (SC), committed 505 
progenitor- (CP), and terminally differentiated (TD) cells. Data shown are from n = 5 506 
independent experiments. Bars in (d–g) represent the average fold change in mRNA 507 
abundance (normalised to 18sRNA) compared to the SC-enriched fraction (red line) in each 508 
experiment. Bars in (h) represent mean ΔCq expression. Error bars represent S.D. P-values 509 
were calculated using one-way ANOVA with Holm Sidak's multiple comparisons test. 510 
(*p<0.05). (i) Western blots of enriched keratinocyte populations (as in d–h) using antibodies 511 
against the TMICD and NEXT fragments of Notch1, 2 or 3, the ICD of Notch1, integrin 512 
(ITG)β1, or involucrin (IVL). Tubulin was used as loading control. Numbers below lanes 513 
represent normalised protein ratios relative to an arbitrary level of 1.0 set for the SC-enriched 514 
fraction. Note that the Notch1 and Notch2 TMICDs and NEXT fragments cannot be 515 
separated sufficiently by SDS-PAGE to appear as discreet bands. (j) Western blots of 516 
keratinocytes cultured in KSFM or FAD, in the presence or absence of DAPT, using 517 
antibodies against the TMICD and NEXT fragment of Notch2, or IVL. GAPDH was used as 518 
loading control. Note accumulation of the Notch2 TMICD and NEXT fragment upon DAPT 519 
treatment in differentiating cells, indicating Notch2 receptor activation upon differentiation 520 
commitment. (k) Schematic illustration summarising expression patterns of different Notch 521 
receptors and ligands. ECM: extracellular matrix. 522 
 523 
Figure 2 Distinct and overlapping roles of Notch receptors and ligands. (a) Western blots of 524 
epidermal sheets generated from keratinocytes (strain km) expressing either a non-targeting 525 
control shRNA (shNTC), or Notch receptor paralogue-silencing shRNAs (set 1, see 526 
Supplementary Table 5), using antibodies against the TMICD and NEXT fragments of 527 
Notch1, 2 or 3, or IVL and ITGβ1. Tubulin was used as loading control. Asterisks indicate 528 
the unprocessed precursor proteins also detected by Notch receptor antibodies. Numbers 529 
below lanes represent protein ratios relative to an arbitrary level of 1.0 set for control samples 530 
(shNTC). (b, c) Clonal growth assays of human keratinocytes (strain km) expressing the 531 
indicated shRNAs. (b) Colony formation efficiency (CFE). Data are from n = 3 independent 532 
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experiments performed with three technical replicates. Individual data points represent 533 
average percentage of colonies formed per number of cells seeded; lines represent the mean. 534 
(c) Distribution of colony area (individual data points). Shown are the pooled data from the 535 
three independent experiments performed in (b); lines represent the mean. P-values were 536 
calculated using unpaired t test with Welsh’s correction. (*p<0.05; ns, not significant). (d) 537 
Quantification of proliferation by human keratinocytes (strain km) expressing the indicated 538 
shRNAs. Data shown are from n = 3 independent experiments. Individual data points 539 
represent the percentage of Ki67-positive cells in each experiment; bars represent the mean. 540 
>500 cells were analysed per experiment. P-values were calculated using unpaired t test with 541 
Welsh’s correction. (*p<0.05). (e) Schematic illustration of the functionalized cell culture 542 
substrates used in (f–i). (f) Representative phase contrast images of sparse cells growing on 543 
cell culture substrates functionalized with the indicated proteins. Arrows indicate cells with 544 
elongated and flattened shapes. Bar, 100 µm. (g) Quantification of spread cell area. Box and 545 
whisker plots indicate the median (middle line in the box), the mean (small crosses), 25th 546 
percentile (bottom line of the box), 75th percentile (top line of the box), and the minimum and 547 
maximum (whiskers). P-values were calculated using one-way ANOVA with Holm Sidak's 548 
multiple comparisons test. (*p<0.05). (h) Q-RT PCR analysis of mRNA levels of terminal 549 
differentiation marker and Notch signalling target genes in cells (strain km) growing in the 550 
presence or absence of DAPT on substrates functionalized with the indicated proteins. Data 551 
shown are from n = 3 independent experiments. Individual data points represent fold change 552 
in mRNA abundance (normalized to 18sRNA) compared to control (cells growing on 553 
substrates functionalized with anti-β2MG antibodies and not treated with DAPT, red lines) in 554 
each experiment. Bars represent the means. Error bars represent S.D. P-values were 555 
calculated using one-way ANOVA with Holm Sidak's multiple comparisons test. (*p<0.05). 556 
(i) Western blots of cells seeded in the presence or absence of DAPT on substrates 557 
functionalized with the indicated proteins, probed with antibodies, as indicated. Tubulin was 558 
used as loading control. Numbers below lanes are protein ratios relative to an arbitrary level 559 
of 1.0 set for control samples (cells growing on substrates functionalized with anti-β2MG 560 
antibodies and not treated with DAPT).  561 
 562 
Figure 3 Notch signalling in spread and rounded cells. (a) Schematic illustration of strategy 563 
used to activate Notch signalling in single SCs by adherence to functionalised micro-564 
patterned substrates. (b) Single cells (strain km) were captured on micro-patterend substrates 565 
functionalized with the indicated proteins and grown in the presence or absence of DAPT. 566 
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Data shown are from n = 3 independent experiments. Individual data points represent fold 567 
change of % TGM1-positive cells relative to the control (cells growing on substrates 568 
functionalized with anti-β2MG antibodies and not treated with DAPT, red lines) in each 569 
experiment. Bars represent the mean. 400–800 single cells were analysed per experiment. P-570 
values for pairwise comparisons were calculated using one-way ANOVA with Holm Sidak's 571 
multiple comparisons test and are listed in Suppl. Table 2. (c) Schematic illustration of 572 
strategy used to activate Notch signalling in single SCs by exposure to functionalised 573 
microbeads. (d–f) SCs (strain km) were captured on 50 µm circular adhesive islands and 574 
exposed to microbeads functionalised with anti-β2MG antibodies or recombinant Jagged1. 575 
(d) Representative phase contrast image. Arrows indicate single cells with one attached bead. 576 
Bar, 50 µm. (e) Percentage of single cells with a single attached bead. >300 cells were 577 
analysed per experiment. (f) Percentage of TGM1-positive single cells with a single attached 578 
bead. 60–75 single cells were analysed per experiment. Data shown are from n = 2 579 
independent experiments (individual data points, bars represent the mean).  580 
 581 
Figure 4 Cis inhibition mediated by Dll1 inhibits Jagged-induced differentiation. (a–c) Q-RT 582 
PCR analysis of mRNA levels of Notch ligands (a), Notch target genes (b) and terminal 583 
differentiation marker (c) in keratinocytes (strain km) transfected with two different Dll1-584 
specific siRNAs or with a non-targeting control (NTC) siRNA and cultured under conditions 585 
that facilitated cell-cell interaction. Data shown are from n = 3 independent experiments 586 
performed with two biological replicates (independent siRNA transfections). Individual data 587 
points represent the average fold change in mRNA abundance (normalized to 18sRNA) 588 
compared to siNTC in each experiment. Bars represent the mean. P-values were calculated 589 
using one-way ANOVA with Holm Sidak's multiple comparisons test. (*p<0.05). (d) Clonal 590 
growth of keratinocytes (strain km) transfected with the indicated siRNAs. Data shown are 591 
from n = 3 independent experiments performed with three technical replicates. Individual 592 
data points represent average percentage of colonies formed per number of cells seeded 593 
(colony formation efficiency, CFE); lines represent the mean. P-values were calculated using 594 
one-way ANOVA with Holm Sidak's multiple comparisons test. (*p<0.05). (e) Schematic 595 
outline of the experimental setup used in (f, g). (f, g ) Q-RT PCR analysis of terminal 596 
differentiation marker expression in keratinocytes (strain km, f; strain kn, g) expressing 597 
zDLL1 or EV 48 hours after seeding onto substrates functionalized with the indicated 598 
proteins. Data shown in f and g are from n = 1 experiment performed with two technical 599 
replicates. Individual data points represent the average fold change in mRNA abundance 600 
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(normalized to 18sRNA) compared to control (EV cells growing on substrates functionalized 601 
with anti-β2MG antibodies) in each experiment. Bars represent the means. 602 
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